Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...

Were you like all of us, a little giddy seeing actual baseball on TV over the last week? Last weekend was the start of the ...

Lloyds, led by boss Charlie Nunn (pictured), has earmarked an extra £700m for compensation on top of a previously announced ...

Lloyds Banking Group saw its annual profit fall below forecasts as it braces itself for the financial fallout from potential ...

Dow drops 400 points as weak consumer sentiment and UnitedHealth slump weigh on US stocks. Inflation fears and PMI data add ...

Governors and lawmakers in some of the fastest growing states are now pursuing tort reform for the same reason the seek to ...

Lloyds Banking Group has nearly tripled the amount it is setting aside to cover the car finance mis-selling scandal to £1.2bn ...

Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood ...

The car loan mis-selling scandal risks blowing a £5.5bn black hole in the public finances, posing a fresh challenge for ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

Trump's tariffs are used as negotiation tools with uncertain long-term effects on inflation and the US dollar's strength.